Send us Feedback

Pharmaceutical Product Development (PPDI)
Analysis
Data
Financials
 
 
Balance Sheet    (USD)
Annual | Quarterly
QUARTER ENDING older 30-SEP
2008		 31-DEC
2008		 31-MAR
2009		 30-JUN
2009		 30-SEP
2009		 newer
Cash & Equivalents 462M 492M 543M 560M 438M
Short Term Investments 47.8M 27.1M 14.2M 13.1M 156M
Accounts Receivable 463M 401M 395M 423M 461M
Inventories 0 0 0 0 0
Pre-paid Expenses 60.5M 27.2M 24.7M 37.5M 23.6M
Deferred Tax Assets 24.2M 28.0M 26.8M 20.9M 19.6M
Other Current Assets 17.9M 43.9M 54.2M 52.8M 72.1M
Total Current Assets 1.08B 1.02B 1.06B 1.11B 1.17B
Property, Plant & Equipment 377M 386M 381M 383M 383M
Goodwill & Intangibles 216M 227M 214M 263M 264M
Other Long-term Assets 117M 104M 116M 115M 118M
Total Long-Term Assets 721M 735M 727M 772M 775M
Total Assets 1.80B 1.75B 1.78B 1.88B 1.94B
Accounts Payable 26.1M 62.4M 60.7M 60.5M 85.4M
Accrued Expenses 184M 0 0 0 0
Short Term Debt 0 0 0 0 0
Other Current Liabilities 286M 247M 242M 267M 281M
Total Current Liabilities 509M 506M 495M 504M 528M
Long Term Debt 0 0 0 0 0
Capital Lease Obligations 0 0 0 0 0
Deferred Income Tax 3.08M 0 0 0 0
Other Long-term Liabilities 68.7M 67.1M 67.9M 72.4M 78.3M
Total Long-term Liabilities 71.8M 67.1M 67.9M 72.4M 78.3M
Minority Interest 0 0 0 0 0
Total Liabilities 581M 573M 563M 576M 607M
Preferred Stock 0 0 0 0 0
Common Par 5.92M 5.88M 5.89M 5.90M 5.91M
Additional Paid-In Capital 543M 545M 556M 561M 570M
Retained Earnings 671M 685M 715M 755M 775M
Treasury Stock 0 0 0 0 0
Other Equity -4.04M -54.5M -54.7M -18.2M -13.1M
Total Shareholder's Equity 1.22B 1.18B 1.22B 1.30B 1.34B
 
 
 
 
 
Data Sources:
Market and financial statement data provided by NASDAQ, BATS Exchange, SEC and Xignite Inc. Industry and operating metrics collected from company filings via EDGAR online. For more information on sources and calculations click here.
Wikinvest © 2006, 2007, 2008, 2009. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki